SPC490
Samsetning af (a) macitentan eða lyfjafræðilega viðunandi salti þar af og (b) tadalafil eða lyfjafræðilega viðunandi salti þar af.
Status:
UmsóknApplication date:
16.12.2024Application published:
15.1.2025
Max expiry date:
27.8.2032Medicine name:
YuvanciMedicine for children:
No
Timeline
Today
16.12.2024Application
15.1.2025Publication
27.8.2032Expires
Marketing license
Foreign authorization number:
EU/1/24/1859Date:
27.9.2024
Owner
Name:
Actelion Pharmaceuticals Ltd.Address:
Gewerbestrasse 16, Allschwil CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2059246